BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 38313027)

  • 1. A commentary on 'The number of metastatic lymph nodes is more predictive of prognosis than location-based N stage for non-small cell lung cancer: a retrospective cohort study'.
    Liang LC; Peng ZY; Mei JD
    Int J Surg; 2024 Mar; 110(3):1802-1803. PubMed ID: 38051930
    [No Abstract]   [Full Text] [Related]  

  • 2. "Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
    Sun W; Qu L; Wu J; Liu X; Wang C; Jiang Y; Liu Y; Chen M; Wang X; Lin D
    Hum Pathol; 2024 May; 149():1-9. PubMed ID: 38782102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of lymph nodes in patients with pT1c33N0M0 non-small cell lung cancer: a retrospective study.
    Yang W; Wang L
    PeerJ; 2024; 12():e16866. PubMed ID: 38313027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of the examined number of lymph nodes at N1 station on the prognosis of patients with pT1-3N0M0 non-small cell lung cancer].
    Wang GX; Li T; Xu SB; Wang J; Xiong R; Xu MQ; Xie MR
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):155-159. PubMed ID: 35184459
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
    Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
    World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of previous extra-pulmonary malignancies on surgical outcomes of sequential primary non-small cell lung cancer.
    Zhang C; Tang X; Liu W; Zheng K; Li X; Ma N; Zhao J
    Heliyon; 2023 Jul; 9(7):e17898. PubMed ID: 37519717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer.
    Nounsi A; Seitlinger J; Ponté C; Demiselle J; Idoux-Gillet Y; Pencreach E; Beau-Faller M; Lindner V; Balloul JM; Quemeneur E; Burckel H; Noël G; Olland A; Fioretti F; Falcoz PE; Benkirane-Jessel N; Hua G
    Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Sublobar Resection for the Surgical Treatment of Non-Small Cell Lung Cancer.
    Behinaein P; Treffalls J; Hutchings H; Okereke IC
    Curr Oncol; 2023 Jul; 30(7):7019-7030. PubMed ID: 37504369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Updated Interpretation of the NCCN Clinical Practice Guidelines (Version 3. 2023) 
for Non-small Cell Lung Cancer].
    Zhu L; Wang T; Wu J; Zhai X; Wu Q; Deng H; Qin C; Tian L; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2023 Jun; 26(6):407-415. PubMed ID: 37488078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSCLC patients with a changing T grade after operation may represent a special subset of tumor staging.
    Feng KP; Fu K; Xu C; Ding C; Zhu XY; Pan B; Jia XY; Zhao J; Li C
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9991-9998. PubMed ID: 37258719
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.